Sosei Group Corporation (SOLTF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 11:05AM EDT
| Previous Close | 8.44 |
| Open | 8.87 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 8.44 - 8.44 |
| 52 Week Range | 8.44 - 21.01 |
| Volume | |
| Avg. Volume | 3 |
| Market Cap | 688.013M |
| Beta (5Y Monthly) | 1.34 |
| PE Ratio (TTM) | 61.16 |
| EPS (TTM) | 0.14 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | Mar 27, 2015 |
| 1y Target Est | N/A |
- Business Wire
Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic Antibodies Against GPCR Targets
SOUTH SAN FRANCISCO, Calif., December 16, 2021--Twist Bioscience Corporation (Nasdaq: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Sosei Group Corporation ("the Company"; TSE: 4565), the world leader in GPCR-focused structure-based drug design (SBDD) and development, announced a strategic collaboration to discover therapeutic antibodies against G protein-coupled receptors (GPCR) identified by Sosei Heptares.
© 2022 Yahoo. All rights reserved.
